PLRX Q2 2020 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$4M100.0% margin

Operating Income

-$17M-471.6% margin

Net Income

-$17M-472.3% margin

EPS (Diluted)

$-1.39

QoQ Revenue Growth

-87.6%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$7M

Stock-Based Comp.

$786,000

Balance Sheet

Total Assets

$329M

Total Liabilities

$13M

Stockholders' Equity

$316M

Cash & Equivalents

$178M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$4M	$0	—
Operating Income	-$17M	-$16M	-7.8%
Net Income	-$17M	-$16M	-9.5%